Recent updates on true potential of an anesthetic agent as a regulator of cell signaling pathways and non-coding RNAs in different cancers: Focusing on the brighter side of propofol
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Propofol Inhibits Lung Cancer A549 Cell Growth and Epithelial‐Mesenchymal Transition Process by Upregulation of MicroRNA-1284Oncology Research, 2018
- Effects of propofol on cancer development and chemotherapy: Potential mechanismsEuropean Journal of Pharmacology, 2018
- Novel Findings of Anti-cancer Property of PropofolAnti-Cancer Agents in Medicinal Chemistry, 2018
- Propofol prevents IL‐13‐induced epithelial–mesenchymal transition in human colorectal cancer cellsCell Biology International, 2018
- Propofol inhibits proliferation, migration, and invasion but promotes apoptosis by regulation of Sox4 in endometrial cancer cellsBrazilian Journal of Medical and Biological Research, 2018
- Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathwayExperimental and Therapeutic Medicine, 2017
- Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathwayBiomedicine & Pharmacotherapy, 2017
- Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptorEuropean Journal of Pharmacology, 2017
- Propofol promotes cell apoptosis via inhibiting HOTAIR mediated mTOR pathway in cervical cancerBiochemical and Biophysical Research Communications, 2015
- Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combinationBritish Journal of Cancer, 2014